These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 17126021)

  • 1. Synthesis of novel quinolone and quinoline-2-carboxylic acid (4-morpholin-4-yl-phenyl)amides: a late-stage diversification approach to potent 5HT1B antagonists.
    Horchler CL; McCauley JP; Hall JE; Snyder DH; Craig Moore W; Hudzik TJ; Chapdelaine MJ
    Bioorg Med Chem; 2007 Jan; 15(2):939-50. PubMed ID: 17126021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [N-methyl-3H3]AZ10419369 binding to the 5-HT1B receptor: in vitro characterization and in vivo receptor occupancy.
    Maier DL; Sobotka-Briner C; Ding M; Powell ME; Jiang Q; Hill G; Heys JR; Elmore CS; Pierson ME; Mrzljak L
    J Pharmacol Exp Ther; 2009 Jul; 330(1):342-51. PubMed ID: 19401496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Synthesis and pharmacologic action of chiral fomocaine ((4-[2-methyl-3-(morpholin-4-yl)propyl)benzyl)-phenyl-ether and (4-(1-methyl-3-(morpholin-4-yl)propyl]benzyl)-phenyl-ether). 13. Synthesis of new compounds with local anesthetic action].
    Oelschläger H; Glassl P; Seeling A; Wange J; Listing M; Jung B
    Pharmazie; 2001 Aug; 56(8):620-5. PubMed ID: 11534337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quinolone carboxylic acids as a novel monoketo acid class of human immunodeficiency virus type 1 integrase inhibitors.
    Sato M; Kawakami H; Motomura T; Aramaki H; Matsuda T; Yamashita M; Ito Y; Matsuzaki Y; Yamataka K; Ikeda S; Shinkai H
    J Med Chem; 2009 Aug; 52(15):4869-82. PubMed ID: 19719237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and serotonergic activity of variously substituted (3-amido)phenylpiperazine derivatives and benzothiophene-4-piperazine derivatives: novel antagonists for the vascular 5-HT1B receptor.
    Moloney GP; Garavelas A; Martin GR; Maxwell M; Glen RC
    Eur J Med Chem; 2004 Apr; 39(4):305-21. PubMed ID: 15072840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kynurenic acid amides as novel NR2B selective NMDA receptor antagonists.
    Borza I; Kolok S; Galgóczy K; Gere A; Horváth C; Farkas S; Greiner I; Domány G
    Bioorg Med Chem Lett; 2007 Jan; 17(2):406-9. PubMed ID: 17074483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and SAR studies of 2-oxoquinoline derivatives as CB2 receptor inverse agonists.
    Raitio KH; Savinainen JR; Vepsäläinen J; Laitinen JT; Poso A; Järvinen T; Nevalainen T
    J Med Chem; 2006 Mar; 49(6):2022-7. PubMed ID: 16539390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [11C]AZ10419369: a selective 5-HT1B receptor radioligand suitable for positron emission tomography (PET). Characterization in the primate brain.
    Pierson ME; Andersson J; Nyberg S; McCarthy DJ; Finnema SJ; Varnäs K; Takano A; Karlsson P; Gulyás B; Medd AM; Lee CM; Powell ME; Heys JR; Potts W; Seneca N; Mrzljak L; Farde L; Halldin C
    Neuroimage; 2008 Jul; 41(3):1075-85. PubMed ID: 18434202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological relationships of 3',6-substituted 2-phenyl-4-quinolone-3-carboxylic acid derivatives as antimitotic agents.
    Lai YY; Huang LJ; Lee KH; Xiao Z; Bastow KF; Yamori T; Kuo SC
    Bioorg Med Chem; 2005 Jan; 13(1):265-75. PubMed ID: 15582470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyrazolo[1,5-a]pyrimidin-7-yl phenyl amides as novel antiproliferative agents: exploration of core and headpiece structure-activity relationships.
    Powell D; Gopalsamy A; Wang YD; Zhang N; Miranda M; McGinnis JP; Rabindran SK
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1641-5. PubMed ID: 17275298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antibacterial activity of 7-(1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazin-7-yl) quinolones.
    Zhu B; Marinelli BA; Goldschmidt R; Foleno BD; Hilliard JJ; Bush K; Macielag MJ
    Bioorg Med Chem Lett; 2009 Sep; 19(17):4933-6. PubMed ID: 19646867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parallel synthesis and dopamine D3/D2 receptor screening of novel {4-[4-(2-methoxyphenyl)piperazin-1-yl]butyl}carboxamides.
    Heidler P; Zohrabi-Kalantari V; Calmels T; Capet M; Berrebi-Bertrand I; Schwartz JC; Stark H; Link A
    Bioorg Med Chem; 2005 Mar; 13(6):2009-14. PubMed ID: 15727854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent antagonists of gonadotropin releasing hormone receptors derived from quinolone-6-carboxamides.
    Walsh TF; Toupence RB; Young JR; Huang SX; Ujjainwalla F; DeVita RJ; Goulet MT; Wyvratt MJ; Fisher MH; Lo JL; Ren N; Yudkovitz JB; Yang YT; Cheng K; Smith RG
    Bioorg Med Chem Lett; 2000 Mar; 10(5):443-7. PubMed ID: 10743944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antibacterial activity of novel 6-fluoro-1-[(1R,2S)-2-fluorocyclopropan-1-yl]-4-oxoquinoline-3-carboxylic acids bearing cyclopropane-fused 2-amino-8-azabicyclo[4.3.0]nonan-8-yl substituents at the C-7 position.
    Inagaki H; Takahashi H; Takemura M
    Bioorg Med Chem Lett; 2004 Oct; 14(20):5193-8. PubMed ID: 15380226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Judicious application of allyl protecting groups for the synthesis of 2-morpholin-4-yl-4-oxo-4H-chromen-8-yl triflate, a key precursor of DNA-dependent protein kinase inhibitors.
    Aristegui SR; El-Murr MD; Golding BT; Griffin RJ; Hardcastle IR
    Org Lett; 2006 Dec; 8(26):5927-9. PubMed ID: 17165896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hit-to-lead optimization of a series of carboxamides of ethyl 2-amino-4-phenylthiazole-5-carboxylates as novel adenosine A2A receptor antagonists.
    Sams AG; Mikkelsen GK; Larsen M; Torup L; Brennum LT; Schrøder TJ; Bang-Andersen B
    Bioorg Med Chem Lett; 2010 Sep; 20(17):5241-4. PubMed ID: 20659802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. APD791, 3-methoxy-n-(3-(1-methyl-1h-pyrazol-5-yl)-4-(2-morpholinoethoxy)phenyl)benzamide, a novel 5-hydroxytryptamine 2A receptor antagonist: pharmacological profile, pharmacokinetics, platelet activity and vascular biology.
    Adams JW; Ramirez J; Shi Y; Thomsen W; Frazer J; Morgan M; Edwards JE; Chen W; Teegarden BR; Xiong Y; Al-Shamma H; Behan DP; Connolly DT
    J Pharmacol Exp Ther; 2009 Oct; 331(1):96-103. PubMed ID: 19628629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a potent and selective 5-HT1B receptor antagonist.
    Wyman PA; Marshall HR; Flynn ST; King RJ; Thompson M; Smith PW; Hadley MS; Price GW; Scott CM; Dawson LA
    Bioorg Med Chem Lett; 2005 Nov; 15(21):4708-12. PubMed ID: 16153839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and anticonvulsant activity of 5-phenyl-[1,2,4]-triazolo[4,3-a]quinolines.
    Guan LP; Jin QH; Wang SF; Li FN; Quan ZS
    Arch Pharm (Weinheim); 2008 Dec; 341(12):774-9. PubMed ID: 19006091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N1-arylsulfonyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole derivatives are potent and selective 5-HT6 receptor antagonists.
    Cole DC; Ellingboe JW; Lennox WJ; Mazandarani H; Smith DL; Stock JR; Zhang G; Zhou P; Schechter LE
    Bioorg Med Chem Lett; 2005 Jan; 15(2):379-83. PubMed ID: 15603958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.